Literature DB >> 35832684

Esthesioneuroblastoma (Olfactory Neuroblastoma): Overview and Extent of Surgical Approach and Skull Base Resection.

Emily E Karp1, Jamie J Van Gompel1,2, Garret Choby1,2.   

Abstract

Esthesioneuroblastoma is a rare malignancy originating from the olfactory epithelium. Treatment consists of surgical resection with strong consideration for adjuvant treatment in advanced Kadish stage and high Hyams grade. In the modern era, overall outcomes for esthesioneuroblastoma are favorable compared with many other sinonasal malignancies with 5-year overall survival estimated to be 80%. When selecting the optimal surgical approach, the surgeon must consider the approach that will allow for a negative margin resection and adequate reconstruction. In appropriately selected patients, endoscopic outcomes appear at least equivalent to open approaches and unilateral endoscopic approach may be used in select olfactory preservation cases. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).

Entities:  

Keywords:  craniofacial resection; endoscopic; esthesioneuroblastoma; neuroblastoma; olfactory

Year:  2022        PMID: 35832684      PMCID: PMC9272014          DOI: 10.1055/s-0042-1753519

Source DB:  PubMed          Journal:  J Neurol Surg Rep        ISSN: 2193-6358


Introduction

Esthesioneuroblastoma is a rare malignancy originating from the olfactory epithelium. Treatment consists of surgical resection with strong consideration for adjuvant treatment in advanced Kadish stage and high Hyams grade. 1 2 In the modern era, overall outcomes for esthesioneuroblastoma are favorable compared with many other sinonasal malignancies with 5-year overall survival estimated to be 80%. 2 3

Case Presentation

A 48-year-old male presented with left-sided nasal obstruction. Magnetic resonance imaging demonstrated invasion of the anterior left cribriform plate into the inferior aspect of the anterior cranial vault, invasion of bilateral olfactory bulbs, and slight extension laterally over the left orbit ( Fig. 1A and B ). Workup demonstrated no regional or distant metastatic disease. This esthesioneuroblastoma was a modified Kadish stage C and Hyams grade 3. The patient underwent surgical resection with endoscopic bilateral craniofacial resection (CFR) ( Fig. 2 ), and margin negative resection was achieved. Reconstruction with pericranium, fascia lata, and extended nasoseptal flap was performed. He completed adjuvant radiation to the anterior skull base and disease free 3 years posttreatment.
Fig. 1

( A ) Case presentation of coronal magnetic resonance imaging, T1 postgadolinium. ( B ) Arrow indicates contralateral olfactory tract involvement.

Fig. 2

Endoscopic bilateral craniofacial resection.

( A ) Case presentation of coronal magnetic resonance imaging, T1 postgadolinium. ( B ) Arrow indicates contralateral olfactory tract involvement. Endoscopic bilateral craniofacial resection.

Overview

Treatment of esthesioneuroblastoma is dependent on the extent of the tumor at presentation. Surgical resection is the mainstay of treatment with consideration for adjuvant radiation with or without chemotherapy. 1 In rare cases, induction chemotherapy may be indicated prior to definitive treatment for locally unresectable tumors. 4 In the modern era, open CFR refers to bifrontal craniotomy combined with assistance from an endoscopic endonasal approach for intranasal tumor resection, margin sampling, and assistance with reconstruction. An open approach is often selected where negative margins are not achievable with endoscopic approaches such as extensive intracranial involvement, orbital invasion, lateral extent of tumor past mid-plane of the orbit, extension to the optic canal and cavernous sinus, or when there is tumor high in the frontal sinus. 1 5 An open approach may also be selected when tumor involvement precludes intranasal reconstructive as it allows for direct dural repair with fascia lata and placement of pericranial flap for cranial base reconstruction. 1 In high-volume skull base centers, many tumors can be addressed with a completely transnasal endoscopic CFR with comparable outcomes to open approaches. 1 5 6 Kadish stage A and B tumors can typically be managed completely endoscopically. Increasingly larger Kadish stage C tumors may be resected solely with an endoscopic approach with clear surgical margins and endoscopic reconstruction. Historical teaching includes resection of bilateral olfactory bulbs and tracts. However, modification of the traditional surgical extent for preserved olfaction may be considered using a unilateral endoscopic skull base resection. 1 7 8 10 Unilateral endoscopic resection may be considered when high-quality preoperative imaging suggests no involvement of contralateral olfactory bulb or tract along with the assistance of intraoperative frozen section margin analysis to ensure complete resection. 7 8

Conclusion

Overall, esthesioneuroblastoma has favorable survival outcomes when compared with other sinonasal malignancies. 2 3 When selecting the optimal surgical approach, the surgeon must consider the approach that will allow for a negative margin resection and adequate reconstruction. In appropriately selected patients, endoscopic outcomes appear at least equivalent to open approaches and unilateral endoscopic approach may be used in select olfactory preservation cases.
  10 in total

1.  Smell preservation following endoscopic unilateral resection of esthesioneuroblastoma: a multi-institutional experience.

Authors:  Bobby A Tajudeen; Nithin D Adappa; Edward C Kuan; Joseph S Schwartz; Jeffrey D Suh; Marilene B Wang; James N Palmer
Journal:  Int Forum Allergy Rhinol       Date:  2016-07-19       Impact factor: 3.858

2.  Esthesioneuroblastoma and Olfactory Preservation: Is it Reasonable to Attempt Smell Preservation?

Authors:  Jamie J Van Gompel; Jeffrey R Janus; Joshua D Hughes; Janalee K Stokken; Eric J Moore; Tarek Ryan; Daniel L Price; Michael J Link
Journal:  J Neurol Surg B Skull Base       Date:  2017-08-28

Review 3.  Comparison of outcomes for open versus endoscopic approaches for olfactory neuroblastoma: A systematic review and individual participant data meta-analysis.

Authors:  Terence S Fu; Eric Monteiro; Nidal Muhanna; David P Goldstein; John R de Almeida
Journal:  Head Neck       Date:  2015-10-30       Impact factor: 3.147

4.  Survival outcomes for stage-matched endoscopic and open resection of olfactory neuroblastoma.

Authors:  Richard J Harvey; Sunny Nalavenkata; Raymond Sacks; Nithin D Adappa; James N Palmer; Michael T Purkey; Rodney J Schlosser; Carl Snyderman; Eric W Wang; Bradford A Woodworth; Robert Smee; Tom Havas; Richard Gallagher
Journal:  Head Neck       Date:  2017-09-25       Impact factor: 3.147

5.  ICAR: endoscopic skull-base surgery.

Authors:  Eric W Wang; Adam M Zanation; Paul A Gardner; Theodore H Schwartz; Jean Anderson Eloy; Nithin D Adappa; Martin Bettag; Benjamin S Bleier; Paolo Cappabianca; Ricardo L Carrau; Roy R Casiano; Luigi M Cavallo; Charles S Ebert; Ivan H El-Sayed; James J Evans; Juan C Fernandez-Miranda; Adam J Folbe; Sebastien Froelich; Fred Gentili; Richard J Harvey; Peter H Hwang; John A Jane; Daniel F Kelly; David Kennedy; Engelbert Knosp; Devyani Lal; John Y K Lee; James K Liu; Valerie J Lund; James N Palmer; Daniel M Prevedello; Rodney J Schlosser; Raj Sindwani; C Arturo Solares; Abtin Tabaee; Charles Teo; Parthasarathy D Thirumala; Brian D Thorp; Eduardo de Arnaldo Silva Vellutini; Ian Witterick; Bradford A Woodworth; Peter-John Wormald; Carl H Snyderman
Journal:  Int Forum Allergy Rhinol       Date:  2019-07       Impact factor: 3.858

Review 6.  Postoperative protocols following endoscopic skull base surgery: An evidence-based review with recommendations.

Authors:  Arash Abiri; Tirth R Patel; Emily Nguyen; Jack L Birkenbeuel; Bobby A Tajudeen; Garret Choby; Eric W Wang; Rodney J Schlosser; James N Palmer; Nithin D Adappa; Edward C Kuan
Journal:  Int Forum Allergy Rhinol       Date:  2022-06-09       Impact factor: 3.858

7.  Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.

Authors:  Matt Lechner; Yoko Takahashi; Mario Turri-Zanoni; Jacklyn Liu; Nicholas Counsell; Mario Hermsen; Raman Preet Kaur; Tianna Zhao; Murugappan Ramanathan; Volker H Schartinger; Oscar Emanuel; Sam Helman; Jordan Varghese; Jozsef Dudas; Herbert Riechelmann; Susanne Sprung; Johannes Haybaeck; David Howard; Nils Wolfgang Engel; Sarah Stewart; Laura Brooks; Jessica C Pickles; Thomas S Jacques; Tim R Fenton; Luke Williams; Francis M Vaz; Paul O'Flynn; Paul Stimpson; Simon Wang; S Alam Hannan; Samit Unadkat; Jonathan Hughes; Raghav Dwivedi; Cillian T Forde; Premjit Randhawa; Simon Gane; Jonathan Joseph; Peter J Andrews; Gary Royle; Alessandro Franchi; Roberta Maragliano; Simonetta Battocchio; Helen Bewicke-Copley; Christodoulos Pipinikas; Amy Webster; Chrissie Thirlwell; Debbie Ho; Andrew Teschendorff; Tianyu Zhu; Christopher D Steele; Nischalan Pillay; Bart Vanhaesebroeck; Ahmed Mohyeldin; Juan Fernandez-Miranda; Ki Wan Park; Quynh-Thu Le; Robert B West; Rami Saade; R Peter Manes; Sacit Bulent Omay; Eugenia M Vining; Benjamin L Judson; Wendell G Yarbrough; Maddalena Sansovini; Nicolini Silvia; Ilaria Grassi; Alberto Bongiovanni; David Capper; Ulrich Schüller; Selvam Thavaraj; Ann Sandison; Pavol Surda; Claire Hopkins; Marco Ferrari; Davide Mattavelli; Vittorio Rampinelli; Fabio Facchetti; Piero Nicolai; Paolo Bossi; Oswaldo A Henriquez; Kelly Magliocca; C Arturo Solares; Sarah K Wise; Jose L Llorente; Zara M Patel; Jayakar V Nayak; Peter H Hwang; Peter D Lacy; Robbie Woods; James P O'Neill; Amrita Jay; Dawn Carnell; Martin D Forster; Masaru Ishii; Nyall R London; Diana M Bell; Gary L Gallia; Paolo Castelnuovo; Stefano Severi; Valerie J Lund; Ehab Y Hanna
Journal:  Eur J Cancer       Date:  2021-12-31       Impact factor: 10.002

8.  Long-term oncologic outcomes in esthesioneuroblastoma: An institutional experience of 143 patients.

Authors:  Ryan A McMillan; Jamie J Van Gompel; Michael J Link; Eric J Moore; Daniel L Price; Janalee K Stokken; Kathryn M Van Abel; Jamie O'Byrne; Caterina Giannini; Ashish Chintakuntlawar; Carlos D Pinheiro Neto; Maria Peris Celda; Robert Foote; Garret Choby
Journal:  Int Forum Allergy Rhinol       Date:  2022-04-06       Impact factor: 5.426

9.  Induction Therapy Prior to Surgical Resection for Patients Presenting with Locally Advanced Esthesioneuroblastoma.

Authors:  Kevin C Miller; John P Marinelli; Jeffrey R Janus; Ashish V Chintakuntlawar; Robert L Foote; Michael J Link; Garret Choby; Jamie J Van Gompel
Journal:  J Neurol Surg B Skull Base       Date:  2020-01-14

10.  Preservation of olfaction after unilateral endoscopic approach for resection of esthesioneuroblastoma.

Authors:  Aaron Wessell; Ameet Singh; Zachary Litvack
Journal:  J Neurol Surg Rep       Date:  2014-06-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.